XPA Gene Xeroderma Pigmentosum Group A Genetic Test sale cost 4400 AED
DLX3 Gene Trichodontoosseous Syndrome Genetic Test sale cost 4400 AED DLX3 Gene Trichodontoosseous Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Nx Gen Sequencing Bethlem Myopathy Myofibrillar Myopathy and Ullrich Muscular Dystrophy Test sale cost 4680 AED Nx Gen Sequencing Bethlem Myopathy Myofibrillar Myopathy and Ullrich Muscular Dystrophy Test Cost 5,200 د.إ Original price was: 5,200 د.إ.4,680 د.إCurrent price is: 4,680 د.إ.
Sale!

XPA Gene Xeroderma Pigmentosum Group A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “XPA Gene Xeroderma Pigmentosum Group A Genetic Test” is a specialized diagnostic procedure aimed at detecting mutations in the XPA gene, which are indicative of Xeroderma Pigmentosum (XP) Group A. This condition is a rare genetic disorder characterized by an extreme sensitivity to ultraviolet (UV) rays from sunlight, leading to a high risk of skin cancers and sunburns, even from minimal sun exposure. Individuals with XP Group A exhibit defects in their DNA repair mechanism, specifically in the nucleotide excision repair pathway, making them unable to effectively repair DNA damage caused by UV light.

The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its expertise in genetic and molecular diagnostics. By analyzing a sample of the patient’s blood or saliva, the test identifies specific mutations in the XPA gene that confirm the diagnosis of Xeroderma Pigmentosum Group A. This information is crucial for the management and treatment of the condition, allowing for personalized care plans that include strict UV protection measures and regular skin examinations to detect and treat cancers early.

The cost of the XPA Gene Xeroderma Pigmentosum Group A Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, the price reflects the intricate processes involved in genetic sequencing and analysis, as well as the expertise required to interpret the results accurately. For families and individuals facing the risk of Xeroderma Pigmentosum, this test offers a valuable tool for early diagnosis and intervention, potentially saving lives by preventing severe skin damage and reducing the risk of skin cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

XPA Gene Xeroderma pigmentosum group A Genetic Test

Cost: AED 4400.0

Test Components:

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test gene XPA.

Test Details:

XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is a genetic test that analyzes the XPA gene for mutations associated with Xeroderma pigmentosum, group A (XP-A). Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) light, leading to severe sunburns, freckling, and an increased risk of skin cancer.

The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, including the XPA gene, to identify any disease-causing mutations. This comprehensive approach increases the accuracy and efficiency of genetic testing, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options for individuals with XP-A.

The XPA gene is responsible for producing a protein involved in DNA repair. Mutations in this gene can impair the ability of cells to repair DNA damage caused by UV light exposure. As a result, individuals with XP-A are more susceptible to developing skin cancer at an early age.

The XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is typically recommended for individuals with clinical symptoms suggestive of XP-A or a family history of the condition. It can help confirm the diagnosis, provide information on disease severity, and guide appropriate management strategies, such as strict sun protection measures and regular skin cancer screenings.

It is important to note that this test is typically performed by healthcare professionals who specialize in genetics or genetic counseling. The results of the test should be interpreted in conjunction with the individual’s clinical presentation and family history to provide accurate genetic counseling and appropriate medical management.

Test Name XPA Gene Xeroderma pigmentosum group A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test gene XPA
Test Details

XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is a genetic test that analyzes the XPA gene for mutations associated with Xeroderma pigmentosum, group A (XP-A). Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) light, leading to severe sunburns, freckling, and an increased risk of skin cancer.

The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, including the XPA gene, to identify any disease-causing mutations. This comprehensive approach increases the accuracy and efficiency of genetic testing, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options for individuals with XP-A.

The XPA gene is responsible for producing a protein involved in DNA repair. Mutations in this gene can impair the ability of cells to repair DNA damage caused by UV light exposure. As a result, individuals with XP-A are more susceptible to developing skin cancer at an early age.

The XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is typically recommended for individuals with clinical symptoms suggestive of XP-A or a family history of the condition. It can help confirm the diagnosis, provide information on disease severity, and guide appropriate management strategies, such as strict sun protection measures and regular skin cancer screenings.

It is important to note that this test is typically performed by healthcare professionals who specialize in genetics or genetic counseling. The results of the test should be interpreted in conjunction with the individual’s clinical presentation and family history to provide accurate genetic counseling and appropriate medical management.

SKU: TEST-3302 Category:

Related products